Cargando…

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: Right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users

Given the importance of glycemic control in the development of diabetes complications, the plethora of tools now available to monitor the day-to-day trends in glycemia is remarkable. In this regard, self-monitoring of blood glucose (SMBG) has been considered a key component of patient management. Ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polonsky, William H., Fisher, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Point-Counterpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526239/ https://www.ncbi.nlm.nih.gov/pubmed/23264290 http://dx.doi.org/10.2337/dc12-0731

Ejemplares similares

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence
por: Malanda, Uriëll L., et al.
Publicado: (2013)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Kleefstra, Nanne, et al.
Publicado: (2009)

Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA randomized trial
por: Bosi, Emanuele, et al.
Publicado: (2013)

Glucose Variability
por: Service, F. John
Publicado: (2013)

Burnout in Medicine: Are We Asking the Right Questions?
por: DePorre, Alexandra, et al.
Publicado: (2023)

Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results from the Structured Testing Program study
por: Polonsky, William H., et al.
Publicado: (2011)

Glucose Variability: Where It Is Important and How to Measure It
por: DeVries, J. Hans
Publicado: (2013)

Point: Postprandial Glucose Levels Are a Clinically Important Treatment Target
por: Ceriello, Antonio
Publicado: (2010)

Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target
por: Davidson, Mayer B.
Publicado: (2010)

Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues
por: Riddle, Matthew C.
Publicado: (2010)

The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study
por: Russo, Giuseppina T., et al.
Publicado: (2016)

Predictors of self-monitoring of blood glucose among noninsulin-treated patients with type 2 diabetes in a primary care setting in Hong Kong: A cross-sectional study
por: Mak, Wing-hang, et al.
Publicado: (2021)

Noninsulin pharmacological management of type 1 diabetes mellitus
por: Garg, Vishvas
Publicado: (2011)

Role of Noninsulin Therapies in the Treatment of Type 1 Diabetes
por: Lingow, Sara E., et al.
Publicado: (2019)

Trace and toxic element patterns in nonsmoker patients with noninsulin-dependent diabetes mellitus, impaired glucose tolerance, and fasting glucose
por: Serdar, Muhittin A., et al.
Publicado: (2009)

The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies
por: Varas-Lorenzo, Cristina, et al.
Publicado: (2014)

Response to Comment on: Polonsky et al. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes: Results From the Structured Testing Program Study. Diabetes Care 2011;34:262–267
por: Polonsky, William H., et al.
Publicado: (2011)

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Kleefstra, Nanne, et al.
Publicado: (2013)

Patient Preferences for Noninsulin Diabetes Medications: A Systematic Review
por: Purnell, Tanjala S., et al.
Publicado: (2014)

Proximal Predictors of Long-Term Discontinuance with Noninsulin Antihyperglycemic Agents
por: Stuart, Bruce C., et al.
Publicado: (2016)

Response to Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Bosi, Emanuele, et al.
Publicado: (2013)

Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy
por: Wright, Eugene E., et al.
Publicado: (2021)

Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time
por: Khan, Mahfuzul H., et al.
Publicado: (2009)

Point: Steady Progress and Current Challenges in Clinical Islet Transplantation
por: Mineo, Davide, et al.
Publicado: (2009)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: A1C remains the gold standard outcome predictor in diabetic dialysis patients
por: Kalantar-Zadeh, Kamyar
Publicado: (2012)

A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death: Time to dispense with the hemoglobin A1C in end-stage kidney disease
por: Freedman, Barry I.
Publicado: (2012)

Response to commentary “Zinc is decreased in prostate cancer: an established relationship of prostate cancer!”
por: Banas, Agnieszka Maria, et al.
Publicado: (2010)

Point: Intensive Glycemic Control and Mortality in ACCORD—A Chance Finding?
por: Lachin, John M.
Publicado: (2010)

Mitochondrial Deficiency Is Associated With Insulin Resistance
por: Goodpaster, Bret H.
Publicado: (2013)

“Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance
por: Holloszy, John O.
Publicado: (2013)

Insulin Analogs—Is There a Compelling Case to Use Them? No!
por: Davidson, Mayer B.
Publicado: (2014)

2012 ESC STEMI guidelines and reperfusion therapy: Evidence base ignored, threatening optimal patient management
por: Terkelsen, Christian Juhl, et al.
Publicado: (2013)

Validity of Meta-analysis in Diabetes: Meta-analysis Is an Indispensable Tool in Evidence Synthesis
por: Golden, Sherita Hill, et al.
Publicado: (2013)

Validity of Meta-analysis in Diabetes: We Need to Be Aware of Its Limitations
por: Home, Philip D.
Publicado: (2013)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies: The benefits by far outweigh the potential risks
por: Nauck, Michael A.
Publicado: (2013)

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment
por: Umpierrez, Guillermo E., et al.
Publicado: (2013)

Is Incretin-Based Therapy Ready for the Care of Hospitalized Patients With Type 2 Diabetes?: The time has come for GLP-1 receptor agonists!
por: Schwartz, Stanley, et al.
Publicado: (2013)

A Critical Analysis of the Clinical Use of Incretin-Based Therapies : Are the GLP-1 therapies safe?
por: Butler, Peter C., et al.
Publicado: (2013)

Advanced Imaging Tools Rather Than Hemodynamics Should Be the Primary Approach for Diagnosing, Following, and Managing Pulmonary Arterial Hypertension
por: Gerges, Mario, et al.
Publicado: (2015)

Vandenbroucke and Pearce Respond to “Incident and Prevalent Exposures and Causal Inference”
por: Vandenbroucke, Jan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ufneq241tng2250qh9eppkudv3